Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-11, Stock:JNJ, The news for the past five days is as follows:
2018-10-04: NEWS1: MARKETS: Don't freak out about today's selloff, but retail is still in trouble.NEWS2: Top Performing ETFs of the Third Quarter.NEWS3: Top Performing ETFs of the Third Quarter.NEWS4: J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion.NEWS5: 7 Healthcare Stocks to Buy Right Now.NEWS6: Seattle Genetics: Impact of the Cascadian Acquisition.NEWS7: Stocks - Apple, Amazon Fall in Pre-market; Barnes & Noble Surges.NEWS8: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS9: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS10: Health-Care Stocks’ High Valuations May Not Be a Problem.NEWS11: Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug.NEWS12: J&J&apos;s Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS13: J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion.NEWS14: The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut.NEWS15: UPDATE: Arrowhead Pharma stock surges 19% on news of $3.7 billion license agreement with Janssen.NEWS16: Eli Lilly’s Stock Performance and Estimates for Q3 2018.NEWS17: Arrowhead Enters $3.7 Bln License And Collaboration Deals With Janssen.NEWS18: Arrowhead Enters $3.7 Bln License And Collaboration Deals With Janssen.NEWS19: Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US.
2018-10-05: NEWS1: Johnson & Johnson Stock in the Week Ended October 5.NEWS2: Cara Therapeutics: Recommendations and Market Capitalization.NEWS3: J&J Inks Deal With Arrowhead for Promising Liver Candidate.NEWS4: J&J Inks Deal With Arrowhead for Promising Liver Candidate.NEWS5: 8 Stocks to Buy That Will Never Go Out of Style.NEWS6: Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data.NEWS7: Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data.NEWS8: J&J Inks Deal With Arrowhead for Promising Liver Candidate.NEWS9: MARKETS: Nike, McDonald's leading the Dow higher, as big banks get a bump.NEWS10: Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data.NEWS11: Health Care Sector Update for 10/05/2018: JNJ, PFE, ABT, MRK, AMGN, HSGX, KMPH.NEWS12: Health Care Sector Update for 10/05/2018: JNJ, PFE, ABT, MRK, AMGN, HSGX, KMPH.NEWS13: What Seattle Genetics’ Valuation Trend Indicates.NEWS14: Bull of the Day: Roche (RHHBY).NEWS15: Bull of the Day: Roche (RHHBY).NEWS16: 7 Healthcare Stocks to Buy Right Now.NEWS17: 7 Healthcare Stocks to Buy Right Now.
2018-10-08: NEWS1: Johnson & Johnson Offers an Attractive Investment Proposition.NEWS2: Notable Monday Option Activity: AKCA, ACN, JNJ.NEWS3: Notable Monday Option Activity: AKCA, ACN, JNJ.NEWS4: Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?.NEWS5: Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?.NEWS6: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS7: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS8: Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Day.NEWS9: Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?.NEWS10: Geron Stock: Buy, Sell, or Hold?.NEWS11: Geron Stock: Buy, Sell, or Hold?.NEWS12: JNJ’s $3.7 Billion Deal for Hepatitis B Gene Silencing Drug.NEWS13: Geron Stock: Buy, Sell, or Hold?.NEWS14: Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?.NEWS15: Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?.NEWS16: How Is Arrowhead Pharmaceuticals Stock Positioned?.NEWS17: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS18: Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?.NEWS19: 8 Stocks to Buy That Will Never Go Out of Style.NEWS20: 8 Stocks to Buy That Will Never Go Out of Style.
2018-10-09: NEWS1: 4 Reasons to Be Wary of This Animal Health IPO.NEWS2: Why Arbutus Biopharma Stock Plunged 24.4% Today.NEWS3: 10 S&P 500 Stocks to Buy for the Long Term.NEWS4: ARWR Stock Sinks After Signing a Big Collaboration Deal.NEWS5: ARWR Stock Sinks After Signing a Big Collaboration Deal.NEWS6: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS7: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS8: Johnson & Johnson (JNJ) Q3 Earnings Preview: Here's What to Look Out For.NEWS9: Johnson & Johnson (JNJ) Q3 Earnings Preview: Here's What to Look Out For.NEWS10: Notable ETF Inflow Detected - QUAL, JNJ, V, XOM.NEWS11: Notable ETF Inflow Detected - QUAL, JNJ, V, XOM.NEWS12: Orchestra BioMed™ Adds Three Industry Leaders to Strategic Advisory Board.NEWS13: Here's Why Geron Plummeted 69% in September.NEWS14: Here's Why Geron Plummeted 69% in September.NEWS15: ARWR Stock Sinks After Signing a Big Collaboration Deal.NEWS16: Johnson & Johnson (JNJ) Q3 Earnings Preview: Here&apos;s What to Look Out For.NEWS17: Here&apos;s Why Geron Plummeted 69% in September.NEWS18: J&J's Stelara succeeds in chronic bowel disease study.NEWS19: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS20: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS21: An Overview of Johnson & Johnson’s Neuroscience Segment.
2018-10-10: NEWS1: Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know.NEWS3: Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know.NEWS4: 5 Healthcare Stocks to Buy for Complete Portfolio Wellness.NEWS5: 5 Healthcare Stocks to Buy for Complete Portfolio Wellness.NEWS6: Alexion Pharmaceuticals’ Operational Performance.NEWS7: Analyzing Alexion Pharmaceuticals’ Top-Line Trends.NEWS8: How Alexion Pharmaceuticals Is Positioned in October.NEWS9: Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates.NEWS10: Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates.NEWS11: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS12: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS13: 5 Healthcare Stocks to Buy for Complete Portfolio Wellness.NEWS14: J&J&apos;s Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS15: How Novartis’s Sandoz Business Has Been Performing Recently.NEWS16: Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates.NEWS17: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS18: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS19: How Intuitive’s Bottom Line Is Expected to Look in Q3 2018.NEWS20: Why Most Analysts Are Bullish on Intuitive Surgical in October.NEWS21: 10 S&P 500 Stocks to Buy for the Long-Term.NEWS22: 10 S&P 500 Stocks to Buy for the Long-Term.

Answer: Decrease